drugset / Trial / NCT00833404

Smoking Cessation and Sexual Health in Men

NCT00833404

Phase 1 Completed 80 enrolled University of Texas at Austin
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a 12-week clinical trial investigating the effects of smoking cessation on sexual functioning in men. This study consists of 3 sessions and provides 8 weeks of free nicotine transdermal patches. It is hypothesized that men who quit smoking, compared to men who smoke as usual, will demonstrate improved sexual functioning, measured both physiologically (erectile functioning) and subjectively (self-reported sexual functioning).

Timeline

Start
2008-12
Primary completion
2010-01
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 21 mg Other

Indications

No indication recorded.